USING YOUR BLUE RELIEVER INHALER* 3 OR MORE TIMES A WEEK?

Take this short test to see if you are one of the many people who rely too much on their Blue Reliever Inhaler.1

Using your Blue Reliever Inhaler 3 or more times a week for your asthma might mean you are relying on it too much.

This could be a sign that your asthma is poorly controlled, putting you at increased risk of an asthma attack. 3

Take this short test to see if you are one of the many people who rely too much on their Blue Reliever Inhaler. 1,2

You can discuss your results with your treatment provider to see if there’s another treatment approach for you.

BEWARE THE TALE OF
TIFFANY TAYLOR

Here lies a video of Tiffany Taylor, a lady too reliant on her reliever inhaler. WATCH and it’ll help you consider your blue, SHARE and it might help others, too.

YOUR VIEWS ABOUT YOUR BLUE RELIEVER INHALER*

Take this short test to see if you are one of the many people who rely too much on their Blue Reliever Inhaler.1,2

Below are things other people have said about their Blue Reliever Inhaler.
Please click on the button that best represents how much you agree, or disagree with each statement.
There are no right or wrong answers. We are interested in your views.

 


The Reliever Reliance Test is adapted from the validated and globally used Beliefs about Medicines Questionnaire and has been developed by leading expert in behavioural medicine, Professor Rob Horne, with colleagues from the International Primary Care Respiratory Group (IPCRG).4 It was fully funded by AstraZeneca UK Limited. The Asthma Right Care initiative is a global movement led by the IPCRG funded by AstraZeneca globally.

This is not medical advice DO NOT stop or change your asthma medication without consulting your health care professional.

This is not medical advice DO NOT stop or change your asthma medication without consulting your health care professional.

REFERENCES

  1. Price D. et al. Asthma control and management in 8,000 European patients: the REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey. NPJ Prim Care Respir Med. 2014;24:14009.
  2. Martyn R. Partridge et al. Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med. 2006;6:13.
  3. Global Initiative for Asthma (GINA). Available at: https://cli.re/GINA (last accessed July 2020).
  4. Horne R, Weinman J, Hankins M. The Beliefs about Medicines Questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication. Psychology & Health. 1999; 14(1):1-24.
  • * Contains a short acting β2-sympathomimetic drug (SABA = short acting β2-agonist) and is prescribed to achieve rapid relief from asthma symptoms.